|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Stock-based compensation expense | ||
| Depreciation | ||
| Loss on fixed assets write-off | ||
| Non-cash lease expense | ||
| Amortization of premiums and discounts on available-for-sale marketable securities | ||
| Amortization of non-cash collaboration revenue | ||
| Change in fair value of long-term investments | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Income tax payable | ||
| Deferred revenue and collaboration advance | ||
| Accrued expenses and other current liabilities | ||
| Operating lease liabilities | ||
| Other non-current liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Purchases of property and equipment | ||
| Proceeds from sale of property and equipment | ||
| Purchases of available-for-sale marketable securities | ||
| Maturities of available-for-sale marketable securities | ||
| Purchases of long-term investments | ||
| Net cash provided by (used in) investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs | ||
| Proceeds from issuance of common stock under the ESPP | ||
| Payment of deferred financing costs | ||
| Net cash provided by (used in) financing activities | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental disclosure of non-cash information | ||
| Conversion of redeemable convertible preferred stock to common stock upon initial public offering | ||
| Issuance of common stock and restricted common stock in exchange for profits interests upon Reorganization | ||
| Reclassification of deferred offering costs paid in prior year to stockholders' equity | ||
| Common shares of Affini-T received for collaboration revenue | ||
| Purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities | ||
| Operating lease right-of-use assets obtained in exchange for new lease liabilities | ||
| Remeasurement of operating right-of use asset and lease liability | ||
| Cash paid for income taxes net of (refunds) (Note 13) | ||
| Reconciliation of cash, cash equivalents and restricted cash | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...
